{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:03:55Z","timestamp":1787051035798,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jctube.2021.100262","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T14:33:35Z","timestamp":1626878015000},"page":"100262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees"],"prefix":"10.1016","volume":"24","author":[{"given":"Ghassan","family":"Ilaiwy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dowdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2021.100262_b0005","unstructured":"World Health Organization. Tuberculosis. 2020; Available at: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tuberculosis. Accessed June 20, 2021."},{"issue":"10","key":"10.1016\/j.jctube.2021.100262_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.jctube.2021.100262_b0015","unstructured":"UNHCR. Syrian Regional Refugee Response. 2020; Available at: https:\/\/data2.unhcr.org\/en\/situations\/syria\/location\/113. Accessed June 3, 2020."},{"issue":"4","key":"10.1016\/j.jctube.2021.100262_b0020","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1089\/hs.2016.0054","article-title":"Refugees of the Syrian Civil War: Impact on Reemerging Infections, Health Services, and Biosecurity in Turkey","volume":"14","author":"Doganay","year":"2016","journal-title":"Health Security"},{"issue":"1","key":"10.1016\/j.jctube.2021.100262_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-08907-y","article-title":"Active and latent tuberculosis in refugees and asylum seekers: a systematic review and meta-analysis","volume":"20","author":"Proen\u00e7a","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jctube.2021.100262_b0030","series-title":"Major Infectious Diseases","article-title":"Tuberculosis","author":"Bloom","year":"2017"},{"issue":"23","key":"10.1016\/j.jctube.2021.100262_b0035","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection","volume":"365","author":"Sterling","year":"2011","journal-title":"New England J. Med."},{"issue":"11","key":"10.1016\/j.jctube.2021.100262_b0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1806808","article-title":"One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis","volume":"380","author":"Swindells","year":"2019","journal-title":"New England J. Med."},{"key":"10.1016\/j.jctube.2021.100262_b0045","unstructured":"UNITAID. Landmark deal secures significant discount on price of medicine to prevent TB. 2019; Available at: https:\/\/unitaid.org\/news-blog\/landmark-deal-secures-significant-discount-on-price-of-medicine-to-prevent-tb\/#en. Accessed June 3, 2020."},{"issue":"12","key":"10.1016\/j.jctube.2021.100262_b0050","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/jamainternmed.2017.3941","article-title":"Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model","volume":"177","author":"Tasillo","year":"2017","journal-title":"JAMA Internal Med."},{"issue":"2","key":"10.1016\/j.jctube.2021.100262_b0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.amepre.2018.04.030","article-title":"Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis","volume":"55","author":"Njie","year":"2018","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.jctube.2021.100262_b0060","unstructured":"World Health Organization. Global Health Observatory data repository.Life tables by country, Syrian Arab Republic. Available at: https:\/\/apps.who.int\/gho\/data\/?theme=main&vid=61620. Accessed February 12, 2020."},{"key":"10.1016\/j.jctube.2021.100262_b0065","unstructured":"World Health Organization. WHO TB burden estimates. 2020; Available at: https:\/\/www.who.int\/tb\/country\/data\/download\/en\/. Accessed February 11, 2020."},{"issue":"9","key":"10.1016\/j.jctube.2021.100262_b0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5588\/ijtld.14.0829","article-title":"Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI","volume":"19","author":"Bliven-Sizemore","year":"2015","journal-title":"Int. J. Tuberculosis Lung Disease"},{"issue":"7","key":"10.1016\/j.jctube.2021.100262_b0075","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/cid\/ciy230","article-title":"Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings","volume":"67","author":"Johnson","year":"2018","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.jctube.2021.100262_b0080","unstructured":"World Health Organization. Estimates of Unit Costs for Patient Services for Turkey. 2010; Available at: https:\/\/www.who.int\/choice\/country\/tur\/cost\/en\/. Accessed February 12, 2020."},{"key":"10.1016\/j.jctube.2021.100262_b0085","unstructured":"U.S. Bureau of Labor Statistics. CPI Inflation Calculator. Available at: https:\/\/www.bls.gov\/data\/inflation_calculator.htm. Accessed February 12, 2020."},{"issue":"7","key":"10.1016\/j.jctube.2021.100262_b0090","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/j.1524-4733.2008.00355.x","article-title":"FitzGerald JM, Health State Utilities in Latent and Active Tuberculosis","volume":"11","author":"Guo","year":"2008","journal-title":"Value in Health"},{"key":"10.1016\/j.jctube.2021.100262_b0095","doi-asserted-by":"crossref","unstructured":"M. Quaife, R. Houben, B. Allwood, T. Cohen, A. Coussens, A. Harries et al. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. The Lancet Respiratory 2020 February 10.","DOI":"10.1016\/S2213-2600(20)30039-4"},{"issue":"15","key":"10.1016\/j.jctube.2021.100262_b0100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-Effectiveness in Health and Medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.jctube.2021.100262_b0105","unstructured":"Asylum Information Database. Health care: Conditions for free health care in Turkey."},{"issue":"7","key":"10.1016\/j.jctube.2021.100262_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022276","article-title":"Potential Economic Viability of Two Proposed Rifapentine-Based Regimens for Treatment of Latent Tuberculosis Infection","volume":"6","author":"Holland","year":"2011","journal-title":"PloS one"},{"key":"10.1016\/j.jctube.2021.100262_b0115","doi-asserted-by":"crossref","unstructured":"Wingate LT, Coleman MS, de la Motte Hurst, Christopher, Semple M, Zhou W, Cetron MS, et al. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program. BMC Public Health 2015;15(1):1201.","DOI":"10.1186\/s12889-015-2530-7"},{"issue":"2","key":"10.1016\/j.jctube.2021.100262_b0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.tube.2014.10.006","article-title":"Hepatotoxicity from antituberculous therapy in the elderly: A systematic review","volume":"95","author":"Hosford","year":"2015","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"issue":"5","key":"10.1016\/j.jctube.2021.100262_b0125","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults","volume":"379","author":"Menzies","year":"2018","journal-title":"New England J. Med."},{"issue":"4","key":"10.1016\/j.jctube.2021.100262_b0130","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M17-0609","article-title":"Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis","volume":"167","author":"Zenner","year":"2017","journal-title":"Annals of Internal Medicine"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579421000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:36:27Z","timestamp":1762500987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579421000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":26,"alternative-id":["S2405579421000516"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100262","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2021.100262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100262"}}